Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Circular RNA Cdr1as inhibits proliferation and delays injury-induced regeneration of the intestinal epithelium.

Autor: Chung HK; Cell Biology Group, Department of Surgery, University of Maryland School of Medicine, Baltimore, Maryland, USA., Xiao L; Cell Biology Group, Department of Surgery, University of Maryland School of Medicine, Baltimore, Maryland, USA.; Baltimore Veterans Affairs Medical Center, Baltimore, Maryland, USA., Han N; Cell Biology Group, Department of Surgery, University of Maryland School of Medicine, Baltimore, Maryland, USA., Chen J; Cell Biology Group, Department of Surgery, University of Maryland School of Medicine, Baltimore, Maryland, USA., Yao V; Cell Biology Group, Department of Surgery, University of Maryland School of Medicine, Baltimore, Maryland, USA., Cairns CM; Cell Biology Group, Department of Surgery, University of Maryland School of Medicine, Baltimore, Maryland, USA., Raufman B; Cell Biology Group, Department of Surgery, University of Maryland School of Medicine, Baltimore, Maryland, USA., Rao JN; Cell Biology Group, Department of Surgery, University of Maryland School of Medicine, Baltimore, Maryland, USA.; Baltimore Veterans Affairs Medical Center, Baltimore, Maryland, USA., Turner DJ; Cell Biology Group, Department of Surgery, University of Maryland School of Medicine, Baltimore, Maryland, USA.; Baltimore Veterans Affairs Medical Center, Baltimore, Maryland, USA., Kozar R; Shock Trauma Center, University of Maryland School of Medicine, Baltimore, Maryland, USA., Gorospe M; Laboratory of Genetics and Genomics, National Institute on Aging-IRP, NIH, Baltimore, Maryland, USA., Wang JY; Cell Biology Group, Department of Surgery, University of Maryland School of Medicine, Baltimore, Maryland, USA.; Baltimore Veterans Affairs Medical Center, Baltimore, Maryland, USA.; Department of Pathology, University of Maryland School of Medicine, Baltimore, Maryland, USA.

Publikováno v: JCI insight [JCI Insight] 2024 Jan 16; Vol. 9 (4). Date of Electronic Publication: 2024 Jan 16.

The capsular polysaccharides of Pasteurella multocida serotypes B and E: Structural, genetic and serological comparisons.

Autor: Michael FS; Vaccine and Emerging Infections Research, Human Health Therapeutics Research Centre, National Research Council, 1200 Montreal Road, Ottawa K1A 0R6, Canada., Cairns CM; Vaccine and Emerging Infections Research, Human Health Therapeutics Research Centre, National Research Council, 1200 Montreal Road, Ottawa K1A 0R6, Canada., Fleming P; Vaccine and Emerging Infections Research, Human Health Therapeutics Research Centre, National Research Council, 1200 Montreal Road, Ottawa K1A 0R6, Canada., Vinogradov EV; Vaccine and Emerging Infections Research, Human Health Therapeutics Research Centre, National Research Council, 1200 Montreal Road, Ottawa K1A 0R6, Canada., Boyce JD; Infection and Immunity Program, Department of Microbiology, Monash Biomedicine Discovery Institute, Monash University, Wellington Rd, Melbourne 3800, Australia., Harper M; Infection and Immunity Program, Department of Microbiology, Monash Biomedicine Discovery Institute, Monash University, Wellington Rd, Melbourne 3800, Australia., Cox AD; Vaccine and Emerging Infections Research, Human Health Therapeutics Research Centre, National Research Council, 1200 Montreal Road, Ottawa K1A 0R6, Canada.

Publikováno v: Glycobiology [Glycobiology] 2021 Apr 01; Vol. 31 (3), pp. 307-314.

Development and Characterization of Mouse Monoclonal Antibodies Specific for Clostridiodes (Clostridium) difficile Lipoteichoic Acid.

Autor: Cairns CM; Vaccine and Emerging Infections Research, Human Health Therapeutics Research Centre, National Research Council, Ottawa, Ontario K1A 0R6, Canada., van Faassen H; Vaccine and Emerging Infections Research, Human Health Therapeutics Research Centre, National Research Council, Ottawa, Ontario K1A 0R6, Canada., St Michael F; Vaccine and Emerging Infections Research, Human Health Therapeutics Research Centre, National Research Council, Ottawa, Ontario K1A 0R6, Canada., Aubry A; Vaccine and Emerging Infections Research, Human Health Therapeutics Research Centre, National Research Council, Ottawa, Ontario K1A 0R6, Canada., Henry KA; Vaccine and Emerging Infections Research, Human Health Therapeutics Research Centre, National Research Council, Ottawa, Ontario K1A 0R6, Canada., Rossotti MA; Vaccine and Emerging Infections Research, Human Health Therapeutics Research Centre, National Research Council, Ottawa, Ontario K1A 0R6, Canada., Logan SM; Vaccine and Emerging Infections Research, Human Health Therapeutics Research Centre, National Research Council, Ottawa, Ontario K1A 0R6, Canada., Hussack G; Vaccine and Emerging Infections Research, Human Health Therapeutics Research Centre, National Research Council, Ottawa, Ontario K1A 0R6, Canada., Gisch N; Division of Bioanalytical Chemistry, Priority Research Area Infections, Research Center Borstel, Leibniz Lung Center, 23845 Borstel, Germany., Hogendorf WFJ; Department of Chemistry, University of Copenhagen, 2100 Copenhagen, Denmark., Pedersen CM; Department of Chemistry, University of Copenhagen, 2100 Copenhagen, Denmark., Cox AD; Vaccine and Emerging Infections Research, Human Health Therapeutics Research Centre, National Research Council, Ottawa, Ontario K1A 0R6, Canada.

Publikováno v: ACS chemical biology [ACS Chem Biol] 2020 Apr 17; Vol. 15 (4), pp. 1050-1058. Date of Electronic Publication: 2020 Apr 01.

Investigating the candidacy of a lipoteichoic acid-based glycoconjugate as a vaccine to combat Clostridium difficile infection.

Autor: Cox AD; Vaccine Program, Human Health Therapeutics Portfolio, National Research Council, Ottawa, ON, K1A 0R6, Canada, Andrew.Cox@nrc-cnrc.gc.ca., St Michael F, Aubry A, Cairns CM, Strong PC, Hayes AC, Logan SM

Publikováno v: Glycoconjugate journal [Glycoconj J] 2013 Dec; Vol. 30 (9), pp. 843-55. Date of Electronic Publication: 2013 Aug 23.